# Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

> **NCT07313176** · — · RECRUITING · sponsor: **Britannia Pharmaceuticals Ltd.** · enrollment: 215 (estimated)

## Conditions studied

- Advanced Parkinson Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT07313176
- **Lead sponsor:** Britannia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2028-10
- **Final completion:** 2029-01
- **Target enrollment:** 215 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313176, "Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07313176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*